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Abstract 
 
Purpose: Histamine is an important inflammatory molecule. Following injury to the 
eye, such as cataract surgery, levels are likely to rise and could contribute to the 
development of posterior capsule opacification (PCO). Consequently, we investigated 
the effect of histamine on signalling pathways and growth rates of human lens cells. 
Methods: Gene expression in the native human lens was determined by analysis of 
Illumina bead array data sets. Calcium signalling was investigated through imaging of 
FURA-2 loaded cells while phosphorylation of ERK, p38 and JNK was assessed 
using the BIOPLEX suspended bead array system. Levels of phosphorylated ERK 
were further assessed using immuno-cytochemistry. Growth rate was assessed in FHL 
124 cells by changes in protein level detected by coomassie blue dye extraction and 
3H-thymidine incorporation. In addition, the human capsular bag model was 
employed; in this system, cell growth was measured as coverage of the central 
posterior capsule. 
Results:  
Non-Pathological Lens: 
Analysis of array data from the human lens revealed that only the H1-receptor sub 
type is detectable; this is exclusively expressed in the epithelial cell population. It was 
also found that the lens had no detectable endogenous ability to produce histamine as 
it lacked histidine decarboxylase, however the lens does express large amounts of 
histamine releasing factor (HRF). Moreover, histamine breakdown genes encoding 
histamine N-methyltransferase and diamine oxidase are expressed. 
Pathological Lens: 
Application of histamine to FHL 124 cells produced a dose-dependent increase in 
intracellular calcium, with detectable responses observed from 1M histamine. 
Responses to 100M histamine were ablated with the use of 10M triprolidine (an H1 
antagonist) and not ranitidine (an H2 antagonist) or thioperamide (an H3 antagonist). 
Addition of 100Μ histamine induced significant elevation of phosphorylated ERK 
and P38; pJNK was also elevated, but this change was not significant. In each case, 
peak response was observed 10 minutes following stimulation. The pattern for levels 
of pERK was also observed using Immuno-cytochemistry with a peak response 
between 5-10mins.  Addition of histamine (≥30M) significantly stimulated FHL 124 
cell growth which was inhibited with the use of 100M triprolidine. Moreover the rate 
of cell coverage of the posterior capsule in capsular bags was accelerated by 100M 
histamine. 
Conclusions: The dominant histamine receptor present in native lens epithelial cells 
is the H1 receptor sub-type. Activation of this receptor induces significant changes in 
calcium and MAPK signalling pathways. In addition, histamine stimulates an 
accelerated growth response that could contribute to PCO progression; therefore, 
histamine receptor antagonists could provide therapeutic benefit following cataract 
surgery. 
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1. Introduction 
 
1.1 The Human Eye 
The eye is a complex sensory organ that detects and interprets photic stimuli (see 
figure 1). The human eye can recognise electromagnetic waves with a wave length 
between 400 and 700nm a region known as visible light. The light is detected by two 
types of photoreceptors found in an epithelial layer at the back of the eye called the 
retina. The two types are rods which operate best in low light conditions and cannot 
recognise colours nor do they produce high quality images, and Cones which differ as 
they work best in lighter conditions, recognise colours and produce high quality 
images {Davson, 1990 #92}.  
 
The structure of the eye is made up of three concentric layers, the inner, middle and 
outer layers. These layers contain different structures and membranes which all serve 
important functions for sight {Davson, 1990 #92}. The outer layer known as the 
fibrous coat contains the sclera, conjunctiva and the cornea and is the attachment 
point for extraocular muscles which control eye movement. The sclera is the fibrous 
layer that makes up the whites of the eyes, the conjunctiva is a thin transparent 
membrane surrounding the sclera which protects the eye, and the cornea found at the 
front of the eye is a transparent membrane involved in focusing light onto the retina 
{Davson, 1990 #92}. The middle layer known as the vascular coat contains the iris, 
the ciliary body and the choroid. The iris is the coloured part of the eye which moves 
in response to light intensity controlling the amount of light that enters the eye. The 
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ciliary body produces the fluid which fills the spaces of the eye and also contains 
muscles which moves the lens so the eye can focus on objects at differing distances 
{Davson, 1990 #92}. Lastly, the choroid is a membrane which contains blood vessels 
providing nutrients to the retina. The inner layer known as the neural coat is also 
known as the retina. The retina covers the entire back of the eye and contains 
photoreceptors connected to nerve fibres. These nerve fibres all converge to form the 
optic nerve and where this occurs is the blind spot {Davson, 1990 #92}. The nerve 
fibres form electrical impulses and the optic nerve carries all the information to the 
brain where it is interpreted and an image is formed. The retina contains different 
regions such as the macula which is involved in high visual acuity and the fovea 
which is the most sensitive part of the macula {Davson, 1990 #92}. When the eyes 
are directed at an object the fovea is where all the light is focused. Apart from these 
external structures, the eye also contains fluids within it {Davson, 1990 #92}.  
Aqueous humor is actively secreted from the ciliary body and is found in the anterior 
and posterior chambers. This fluid helps to maintain the shape of the eye but also 
provides nutrients to parts of the eye which do not have access to blood vessels and 
removes waste products {Davson, 1990 #92}. The bulk of the internal space of the 
eye contains the vitreous humor. This is not produced or turned over as readily as the 
aqueous humor and is found in the rear of the eye and has a gel-like consistency.  The 
vitreous humour is essential for maintaining the structure of the eye. Separating the 
two humours is the lens which is required to focus light successfully onto the retina 
through the process of accommodation {Davson, 1990 #92}. 
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1.2 The Lens 
The lens is a transparent bi-convex disk found between the aqueous and vitreous 
humors. It is connected by suspensory ligaments (zonules), made from the protein 
fibrillin, to the ciliary muscles. The lens focuses light onto the retina and its thickness 
and curvature can be changed by the ciliary muscles to refract light more or less so 
objects at different distances can be focused {G. Duncan, 2001 #93}. The process of 
changing lens shape is called accommodation. Accommodation can be a reflex or 
consciously controlled and changes can occur within 350milliseconds. The ability of 
the lens to change its optical power diminishes with age and by the age of 60 nearly 
all people require aids for near vision. This is a condition known as presbyopia. The 
lens is derived from cells of surface ectodermal origin {G. Duncan, 1997 #53}. In the 
mature lens, the lens is enveloped by a collagenous capsule; on the anterior surface 
there is a monolayer of epithelial cells.  Cells at the centre of this epithelium do not 
normally divide or undergo cell death. At the periphery of the epithelium, also known 
as the equator, cells do divide and differentiate into fibre cells {G. Duncan, 1997 #53} 
which form the bulk of the lens; these events are slow but persistent (Figure 1.1). New 
fibre cells are laid down upon the older ones which are internalised forming a fibre 
cell age gradient through the lens. This also forms a well ordered structure through the 
lens preventing light scattering. As the cells differentiate into mature fibre cells they 
lose there nucleus and organelles and accumulate the transparent proteins α, β and γ 
crystallins {G. Duncan, 2001 #93}.  The crystallins provide refractive power of the 
lens and thus contribute to light focusing abilities of the lens. The lens contains no 
blood vessels and therefore all the nutrients required by the cells that make up the lens 
must come from the fluids which surround the lens; the aqueous and vitreous humors 
{I. M. Wormstone, 2006 #83}. The anterior epithelial layer of the lens is connected to  
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Germinative cells 
Fig. 1.1. A diagrammatic representation of a cross section of humans lens (Maidment et 
l 2004) 
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the fibre cells through gap junctions, mainly at the equator, and produce energy which 
allows for the transport of small molecules and metabolites to the fibre cells {G. 
Duncan, 2001 #93}. This maintains the correct ion and metabolite concentration and 
prevents the crystallins from aggregating. If the integrity of the lens is disrupted then 
cataract can result.  
 
1.3 Cataract 
Cataract is a condition defined by an impairment of vision due to opacity forming in 
the lens. There are many causes of cataract such as age, long term exposure to 
ultraviolet light, physical or surgical trauma and in some cases due to other diseases 
such as diabetes. There is also evidence of a genetic susceptibility and cataracts can 
run in families. There are many different types of cataract with three main types. 
Nuclear cataracts are classically associated with old age, form in the centre of the lens 
and are associated with a yellowing/browning (brunescene) of the lens. This is caused 
by proteins within the lens aggregating together which causes light scattering affects 
and blue light absorption {G. Duncan, 2001 #93}. Cortical cataracts are characterised 
by wedge shaped opacities which encroach into the centre of the lens from the 
periphery. They are thought to be cause by an electrolyte imbalance. Cortical cataracts 
have been associated with imbalances in osmotic pressure within the eye and from 
exposure to ultraviolet light {G. Duncan, 2001 #93}. The other relatively common 
form is posterior subcapsular cataract which is characterised by opacity in the 
posterior pole region of the lens. These are thought to be caused by damage to a fibre 
cell in the anterior pole region and the damage spreads from pole to pole. They have 
also been associated with irradiation, diabetes and retinal degradation {G. Duncan, 
2001 #93}. There is no cure for cataract, and the only available treatment is surgery. 
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Modern cataract surgery adopts a procedure known as extracapsular cataract 
extraction {G. Duncan, 2001 #93}. This involves making an opening in the anterior of 
the lens and removing the cataract material. This leaves a capsular bag made up of the 
complete posterior capsule and a ring of anterior capsule. An artificial lens known as 
an intra-ocular lens (IOL) can be implanted, held in place with support loops, within 
the capsular bag, restoring vision. The success of cataract surgery is still affected by 
complications later in life such a retinal detachment and a secondary loss of vision 
resulting from post-surgical wounding, a condition known as posterior capsule 
opacification (PCO). 
 
 
1.4 Posterior Capsule Opacification 
PCO is the most common complication of cataract surgery affecting significant 
proportions of cataract patients {I. M. Wormstone, 2009 #81}. Immediately following 
surgery, light can pass along the visual axis through the IOL and the acellular 
posterior capsule without disruption. However, residual lens epithelial cells on the 
anterior capsule survive the rigours of surgery and begin to re-colonise the anterior 
capsule, the IOL and the posterior capsule and eventually make inroads across the 
visual axis. These cells also begin to undergo changes in organisation and the matrix 
is altered so that the light is scattered. If this continues to develop surgery is often 
required {I. M. Wormstone, 2009 #81} (Figure 1.2).  
 
The incidence of PCO is influenced by a number of factors including age. With 
respect to age, rates are higher in younger patients (up to 70% after 4 years) compared 
with older patients, which was approximately 40% over the same time frame {J.  
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Fig. 1.2. Diagram of (A) the post surgical capsular bag and (B) proliferation and 
morphological changes that cause Posterior capsule opacification. (C) A dark-field 
micrograph of a capsular bag removed from a donor eye that had undergone cataract 
surgery prior to death that exhibits light scattering regions beneath an intraocular 
lens. Previously published in Wormstone, 2002 and Wormstone, 2009. 
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Moisseiev, 1989 #94}. In children the problem is even more severe {W. F. Astle, 
2009 #95}. While there is clearly a greater incidence of PCO in the young, the 
frequency is still significant for all age groups. The majority of patients undergoing 
cataract surgery will be >60 years and an incidence of 10-30% in this group will mean 
millions worldwide are affected by PCO formation. Consequently, significant 
numbers require further surgery to correct the condition and restore vision through 
ablation of light scattering regions on the posterior capsule using a Nd:YAG laser; 
this is both expensive and as with all surgery has risks {I. M. Wormstone, 2009 #81}. 
Due to the importance of PCO, new ways of preventing this cellular growth and 
migration have been developed with mixed results. 
 
Different strategies have been developed to improve management of PCO. The major 
areas of investigation are to improve surgical methods and IOL design. The second is 
to employ agents to control cell behaviour following surgery. i.e. to kill the cells, 
prevent growth, or inhibit , matrix modification. In all cases the aim is to reduce light 
scatter {I. M. Wormstone, 2009 #81}.  
 
Improvements in IOL design led to the production of the “sharp edged” IOL. Through 
interaction with the capsule the edge of the IOL forms a physical barrier to prevent 
the epithelial cells growing on to the central posterior capsule {O. Nishi, 2007 #96}. 
This has helped to reduce the incidence of patients requiring further surgery. However 
this approach seems to delay the point at which PCO becomes clinically relevant, but 
does not prevent it with many patients still requiring laser treatment.  
 
Other areas of research into preventing PCO include the use of molecular agonists to 
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kill or stop the growth of the epithelial cells {G. Duncan, 1997 #97} {G. Duncan, 
2007 #98} {J. L. Walker, 2007 #99} {R. J. Stump, 2006 #100}. Such developments 
will benefit greatly from improved methods of drug delivery at the time of cataract 
surgery {G. Duncan, 2007 #98} {T. M. Rabsilber, 2007 #101}. The identification of 
novel biological targets allied to efficient delivery systems will allow effective 
targeted inhibition of lens cells, while reducing the risk of damage to other ocular 
tissues.  
 
The focus of a large body of research is therefore on what mechanisms result in the 
cellular changes that lead to PCO. Cells respond to signals found in their environment 
and lens cells can respond to either signals they generate themselves (autocrine 
signals) or external signals from other ocular tissues (paracrine signalling) 
{Wormstone, 2002 #50}. Both are thought to contribute to PCO as a constant supply 
of signalling molecules are required to maintain growth and the health of the cells. 
The paracrine signals that underlie PCO are thought to be derived from an increase in 
proteins found in the aqueous humour following cataract surgery {I. M. Wormstone, 
2009 #81}. These come from a disruption in neighbouring blood vessels and an 
inflammatory response. Many of these proteins are only found following surgery and 
are not usually present in the aqueous humour. Many of these proteins, especially 
cytokines, have been shown to increase both cell survival and cell proliferation {Y. 
Ishizaki, 1993 #102} {I. M. Wormstone, 2000 #103} {I. M. Wormstone, 2001 #104} 
{J. M. Maidment, 2004 #69}, two properties that play major parts in PCO formation 
(Figure 3). In addition, there is a great deal of focus on the possible role of 
Transforming Growth Factor beta (TGFβ) which is known to be able to induce 
morphological changes in many cell types and could induce the fibrotic changes 
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which cause light scattering in PCO {A. Leask, 2004 #105 {Massagué, 2000 #106} 
{R. Derynck, 2003 #107} (Figure 1.3). 
 
 
 
 
 
 
The increased levels of proteins in the aqueous humour return to normal levels in the 
weeks and months after surgery. Interestingly however PCO can take years until 
surgery is necessary, therefore an autocrine system is likely to be driving PCO 
Fig. 1.3. Diagram of (A) the early stage events following cataract surgery that lead to PCO 
and (B) the functional outputs of different growth factors in relation to PCO (Wormstone, 
2009). 
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development {Wormstone, 2002 #50}. This would take the form of the normal levels 
of protein in the aqueous humour driving PCO or that signals endogenously produced 
by the lens drive PCO. It is known that the inflammatory response following cataract 
surgery has the ability to change the composition of proteins in the aqueous humour 
and the pattern of protein expression in the lens {Wormstone, 2002 #50}. The lens is 
also known to have many autocrine systems.  It has been shown that the lens is a large 
contributor to transferrin in the aqueous humour {M. C. McGahan, 1995 #109} and 
has many autocrine systems for the production of cytokines and receptors {I. M. 
Wormstone, 2001 #104} {E. H. Lee, 1999 #110}. These autocrine systems are 
demonstrated by the fact that cultured lens cells can survive and proliferate for greater 
than 100 days in serum free medium {I. M. Wormstone, 1997 #108}. This shows an 
autocrine signalling mechanism that can maintain lens cells without external 
regulation. This survival and proliferation has been shown to allow lens cells to 
respond to damage of the lens and grow across the posterior capsule of a capsular bag 
(a model for cataract surgery) (Figure 1.2). Capsular bags from young donors were 
shown to be colonised much quicker than those from older patients {I. M. 
Wormstone, 1997 #108}. Supplementing the capsular bags with 10%FCS sped up 
proliferation with the older donors but less so in the younger donors which means 
autocrine signalling is likely to diminish with age.{I. M. Wormstone, 1997 #108}.  
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In the formation of PCO, both paracrine and autocrine signalling is likely to 
contribute. At the early stages following cataract surgery exogenous proteins will 
cause an initial drive in wound-healing response (Figure 3). This will be maintained 
through the action of autocrine control systems. These systems are likely to drive 
PCO at a slower rate than the early stages as the level of protein will have dropped. 
Therefore each mode of regulation is a worthy area of investigation. The focus of the 
current study was to investigate the role of the inflammatory molecule histamine in 
relation to PCO. 
 
 
 
1.5 Histamine 
Histamine is a biogenic amine with a wide array of functions in all parts of the body. 
It plays major roles as a neurotransmitter, in gastric acid secretion and immune-
regulation {S. J. Hill, 1997 #44}. Histamine was first identified to play a role in 
inflammation and smooth muscle contraction which led to the development of 
antihistamines to block the effect of histamine in these tissues {Hill, 1990 #11}. The 
fact that these antagonists did not affect the ability of histamine to affect other tissues 
showed that different histamine receptors played different roles in different tissues of 
the body. Histamine is now known to be produced in a large number of cells in the 
body including mast cells, basophils, platelets, enterochromaffin-like cells, 
endothelial cells, and neurons, {M. Jutel, 2002 #47} through histidine 
decarboxylation mediated by the enzyme histidine decarboxylase {Stark, 2007 #45}. 
Once produced histamine can be stored in mast cells and basophils so that it can be 
released in relatively large quantities when required. This means that large amounts of 
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histamine are available throughout the body. The levels of histamine are regulated 
through the actions of breakdown enzymes Diamine oxidase (DAO) and histamine N-
methyltransferase (HNMT) {K. Yamauchi, 1994 #85} {Schayer, 1956 #86}.  
 
1.6 Histamine receptors 
Histamine regulates its functions through 3 main types of G-protein coupled 
receptors, HRH1-3. A fourth receptor has also been recently discovered called HRH4 
{Stark, 2007 #45}. HRH1 is found in most smooth muscle, endothelial cells, adrenal 
medulla, heart, and the CNS. It is known to play roles in Smooth muscle contraction, 
stimulation of NO formation, endothelial cell contraction, increased vascular 
permeability, stimulation of hormone release, negative inotropism, depolarization 
(block of leak potassium current) and increased neuronal firing, inositol phospholipid 
hydrolysis and calcium mobilization, hyperpolarization by Ca2+ -dependent potassium 
current. HRH1 signals through a Gαq/11 receptor. This causes the activation of 
phospholipase C (PLC}and an increase in inositol 1,4,5- trisphosphate (IP3) and 1.2-
diacylglycerol (DAG) which leads to an increase in intracellular calcium 
concentration and/or cAMP {Stark, 2007 #45} {S. J. Hill, 1997 #44} {Hill, 1990 
#11}. 
 
HRH2 receptor is found in Gastric parietal cells, vascular smooth muscle, suppressor 
T cells, neutrophils, CNS, and the heart. It is known to play roles in the stimulation of 
gastric acid secretion, smooth muscle relaxation, stimulation of adenylyl  cyclase, 
positive chronotropic and inotropic effects on cardiac muscle, decreased firing rate, 
hyperpolarization or facilitation of signal transduction in CNS, blocking of Ca2+ -
dependent potassium conductance, increase of hyperpolarization-activated current,and 
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the inhibition of lymphocyte function. HRH2 signals through a Gs coupled receptor. 
This leads to the activation of adenylyl cyclase and an increase in cAMP. However it 
has also been observed that HRH2 can lead to activation of PLC and an increase in 
intracellular calcium concentration {Stark, 2007 #45} {S. J. Hill, 1997 #44} {Hill, 
1990 #11}. 
 
Histamine HRH3 receptor is found in the CNS, peripheral nerves (heart, lung, 
gastrointestinal tract), endothelium, and enterochromaffin cells. It is known to play 
roles in the inhibition of neurotransmitter release, inhibition of gastric acid secretion 
(dog), increase in smooth muscle voltage-dependent Ca2+ current, and inhibition of 
the firing of tuberomammilary (histaminergic) neurons. HRH3 signals through Gαi 
and Gαo coupled receptors. This leads to inhibition of adenylyl cyclase and the N+/H+ 
antiporter and activation of mitogenactivated protein kinase (MAPK), phospholipase 
A2, and Akt kinases {Stark, 2007 #45} {S. J. Hill, 1997 #44} {Hill, 1990 #11}. 
 
HRH4 receptor is found at low levels in most tissues and therefore is most likely 
involved in inflammatory processes. This is supported by the fact that anti-histamines 
that target HRH4 have anti inflammatory properties. Also levels of HRH4 receptor 
expression are regulated by various cytokines including IL-6, -10 and -13.    HRH4 
also signals through Gαi and Gαo receptors. This leads to inhibition of adenylyl 
cyclase and reduces levels of cAMP and activation of MAPK and phospholipase C 
causing an increase in intracellular calcium {Stark, 2007 #45} {S. J. Hill, 1997 #44} 
{Hill, 1990 #11}.  
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1.7 Histamine and the Eye 
Histamine is stored in various compartments of the eye including the ciliary body and 
the iris {McMenamin, 1997 #55}{May, 1999 #34} {T. Nakagami, 1999 #35}. The 
availability of these stores is perhaps mostly widely drawn upon during acute and 
chronic inflammation. Histamine has been linked to a number of diseases in the eye 
including pterygia and uveitis {K. Yamashiro, 2001 #57} {N. Girolamoa, 2004 #15}. 
Levels of histamine released from mast cells have been shown to increase during the 
onset of uveitis {C. H. Lee, 1993 #56}. Histamine receptor HRH1 has also been 
found to be expressed in Pterygial derived fibroblasts {R. Maini, 2002 #60}. Pterygial 
fibroblasts and epithelial cells have a greater growth rate than normal conjunctival 
cells and a greater sensitivity to growth factors. There is also a greater density of mast 
cells in pterygial tissue compared to normal conjunctiva. Histamine signalling through 
HRH1 and HRH2 has been shown to cause both proliferation and migration and in 
sub-conjunctival fibroblasts {A. Leonardi, 1999 #74}; proliferation was inhibited with 
the use of an H1 antagonist though migration was not. Histamine has also been shown 
to play a possible role in vernal keratoconjunctivitis (VKC). Histamine stimulated 
VKC cells and normal conjunctival cells to grow at similar rates while VKC’s usually 
grow faster. This growth was inhibited by both HRH1 and HRH2 antagonists {A. 
Leonardi, 1999 #74}. Histamine also promoted cell migration after wounding which 
was inhibited by HRH2 antagonists. Lastly histamine caused VKC fibroblasts to 
produce more PIP than normal cells and normal fibroblasts. This was not prevented 
by HRH1 or HRH2 antagonists and could therefore be caused by a different receptor 
{A. Leonardi, 1999 #74}. 
 
Within the lens itself histamine has been shown to induce calcium mobilisation in 
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native human lens cells and this was inhibited with the use of a HRH1 antagonist {R. 
A. Riach, 1995 #6}. This demonstrates the lens ability to respond to histamine that is 
produced either endogenously or available in the surrounding environment. 
 
1.8 Histamine Signalling 
Histamine receptors can signal through the release of intracellular calcium (Ca2+) 
(HRH1 and HRH2), by the increase in cyclic adenosine mono-phosphate (cAMP) 
(HRH2) or by a decrease in cAMP (HRH3 and HRH4) {S. J. Hill, 1997 #44} {Stark, 
2007 #45}. This can lead to the activation of other signalling pathways such as 
MAPK cascades through signalling pathway crosstalk {A. J. Robinson, 2001 #61} {F. 
Hao, 2008 #14}.  
 
Ca2+ is a versatile and powerful messenger in cells. It regulates multiple cellular 
functions involving many different signalling molecules {Clapham, 2007 #87}. Ca2+ 
can also react with other signalling pathways to create even more diversity in output. 
All the components of Ca2+ signalling form the calcium signalling ‘toolkit’. Each 
component of the toolkit often comprises molecules with slight variations allowing 
cells to have a large number of Ca2+  signalling pathways. The components in the 
toolkit are divided into four main stages of calcium signalling: 
 
• Stimulus that leads to signals for causing Ca2+ release. 
• These ON signals lead to a release of Ca2+ into the cytoplasm 
• Ca2+ acts as a messenger stimulating many Ca2+ sensitive processes. 
• Feedback leads to OFF a signal which removes cytoplasmic Ca2+ 
through membrane pumps and exchangers. 
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Histamine, mainly through the HRH1 but also through the HRH2 receptor, is known 
to cause Ca2+  mobilisation through the activation of PLC which produces inositol-
1,4,5-trisphosphate and diacylglycerol DAG {S. J. Hill, 1997 #44} {Stark, 2007 #45}. 
Inositol-1,4,5-trisphosphate then bind to receptors on the endoplasmic reticulum 
causing the release of Ca2+. Ca2+  can then cause the activation of the MAPK pathway 
through the proline rich tyrosine kinase 2 (PYK2) and Ras. Ca2+  can also cause the 
expression of a metalloproteinase that would liberate EGF that could then signal 
through the MAPK pathway. MAPK signalling cascades are involved in a wide 
variety of cellular functions including proliferation and migration. Signalling occurs 
through the phosphorylation of a series of secondary messengers until the activation 
of several transcription factors lead to a cellular response. There are three MAPK 
pathways p38, JNK and ERK which all cause similar cellular responses but signal 
through different secondary messengers {M. J. Berridge, 2000 #3}. 
 
 
To enable cell proliferation, a major process in PCO development, increased 
intracellular Ca2 must be maintained for a long period (>2 hours) and involves an 
influx of extracellular Ca2+ to maintain Ca2+ levels. If this can be maintained Ca2+ 
activates transcription factors which can then drive proliferation. If Ca2+ levels drop 
then transcription factors are quickly deactivated and translocated out of the nucleus 
{M. J. Berridge, 2000 #3}. 
 
1.9 Interleukins and other cytokines 
Cytokines are a group of polypeptides and glycoproteins that are similar to hormones 
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but are produced locally rather than part of the endocrine system. They act mainly as 
part of autocrine and paracrine systems and are potent in small concentrations 
{Stadnyk, 1994 #5}. The levels of cytokines can increase dramatically as one 
cytokine triggers the release of another and so on. Cytokines can also feedback to 
inhibit further release {K. Arai, 1990 #89}. Histamine is reported to cause the 
production of interleukins IL-6 and -8 and GM-CSF through the HRH1 receptor in 
conjunctival epithelial cells {J. M. Yanni, 1999 #46}.  IL-6 and IL-8 are key 
mediators of the inflammatory response {A. Harada, 1994 #90} {Snick, 1990 #91}. 
IL-8 has been shown to promote cell survival and proliferation in endothelial cells {A. 
Li, 2003 #48}. IL-6 can signal through JAK/STAT, MAPK cascades and through 
PI3K signalling which all have the potential to promote cell proliferation {P. C. 
Heinrich, 2003 #65}. IL-8 signals through G-protein coupled receptors that activate 
PLC and the production of inositol 1,4,5-trisphosphate {D. Wu, 1993 #49}. As 
discussed earlier this is also linked with cell proliferation among many functions. 
Cytokines are a good avenue of investigation as they have a solid link with histamine 
signalling and are known to promote cell proliferation and survival in some cell lines.  
 
1.10 Hypothesis 
Histamine can induce functional changes in Lens cells that are linked with the 
development of PCO. 
 
1.11 Aims and Objectives 
The main aims of this project are to demonstrate that histamine can induce functional 
changes in the lens cell line FHL-124 cells that play a role in the development of 
PCO. The main early stage change in lens cells in PCO is an increase in proliferation 
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therefore the main focus of the project will be to investigate if histamine can induce 
proliferation in FHL-124 cells and which signalling pathways histamine signals 
through to cause this. This will be achieved through the use of a simple growth assay 
called a patch assay. This assay allows you to measure levels of cellular proliferation 
through measuring the size of the patch in relation to a control group and through 
measurement of total protein level. If this growth can be demonstrated then the 
signalling pathways triggered by histamine will be analysed to find which pathways 
are involved in histamine induced proliferation. First Ca2+ imaging will be used to see 
if histamine can mobilise intracellular Ca2+ in FHL-124 cells. Histamine receptor 
antagonists can be used to find which receptor is responsible for any response. It is 
expected that Histamine will produce a response as this has been demonstrated 
previously in native lens cells. BIOplex will also be employed to look at the 
expression of MAPK pathway proteins in response to histamine. If any of these 
pathways are found to be involved then these pathways can be blocked using 
antagonists or SiRNA during growth assays to see if they inhibit histamine induced 
proliferation. Away from this main focus gene array data from FHL-124 cells will be 
analysed to see if any genes that are associated with histamine are present in the lens. 
This will be achieved by using the NCBI website gene search function.  
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2. Materials and Methods 
 
2.1 Cell culture of FHL-124’s 
The human lens cell line FHL-124 was used for all the experiments in this project. 
These were generated in the laboratory of Dr John Reddan (Oakland University, MI) 
from human capsule-epithelial explants {I. M. Wormstone, 2000 #103}. The FHL-
124 cells were seeded on to 35mm culture dishes (BD Falcon, Oxford, UK) (patch 
growth assays, real time PCR and western blots) or on to cover slips (VWR 
International, Lutterworth, Leicestershire) (Immuno-cytochemistry). Cells were 
maintained in EMEM (Sigma, Poole, Dorset) supplemented with 5% foetal calf serum 
(FCS) (Gibco, Paisley, Scotland) until confluent and then typically maintained in 
serum free EMEM for 24 hours before exposure to experimental conditions.  
 
2.2 Gene array analysis 
A retrospective analysis of a gene array data set was performed as part of the 
investigations of histamine function in the lens. The original data set had been 
generated by Dr Lisa Hodgkinson, as part of her PhD studies in the Wormstone lab, 
and a collaborator James Hadfield at the Genomics Facility at The Cancer Research 
Institute, UK, Cambridge. A brief summary of the protocol that produced the original 
data set is as follows.  
 
Four clear human lenses from donors aged 57, 76, 77 and 78 years were separated 
into three distinct regions, namely the central epithelium, the peripheral 
epithelium/equator and fibre cells. Samples were snap-frozen and stored in a -80C 
freezer prior to extracting RNA using the RNeasy® mini kit (Qiagen Ltd, Crawley, 
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UK). A microarray platform was selected to provide a comprehensive view of the 
gene activity in 3 regions of the human lens.  It was also important that data could be 
generated from small samples to allow evaluation of gene expression in individual 
donors.  To achieve this the commercially available Human-6 v2 Expression 
BeadChip (Illumina, San Diego, CA., BD-25-113) array platform was used in 
accordance with manufacturers instructions. Each BeadChip allows simultaneous 
analysis of 6 arrays, each with >46,000 probes derived from human genes in the 
National Centre for Biotechnology Information (NCBI) Reference Sequence.  To 
quantitate mRNA levels 1.8 million beads are available on the Human- v2 BeadChip.  
Each bead is designed with an optimised gene specific 50mer oligo probe, each bead 
has several thousand copies of each probe on its surface.  Concatenated to the probe is 
a short bead address sequence used during the manufacture process to identify the 
bead (Figure 2.1).  The Bead chips were imaged using Illumina’s Bead Array Reader. 
The raw data generated were analysed using Gene Spring software (Agilent 
Technologies UK Limited, South Queensferry, UK), which recognises the Illumina 
bead array platform and normalises the data using internal controls. Normalised signal 
data was then used to generate spreadsheets stored on Excel for future interrogation. 
In the current study this data set was analysed to determine gene expression patterns 
of genes involved in histamine regulation and function. Genes related to histamine 
were found using the NCBI website gene search function. 
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Fig. 2.1. Basic illumina bead design showing an identifier/address region (red) and a 50mer probe. 
http://www.switchtoi.com/pdf/GXHuman6-8v2Datasheet.pdf 
 
 
 
2.3 Patch Growth Assay 
5000 cells in 100µl EMEM (Sigma, Poole, Dorset) supplemented with 5% FCS were 
seeded at four distinct sites (Patches) on 35mm tissue culture dishes. The cells were 
left to adhere and until the patches were confluent. The medium was removed and 
cells placed in 1.5mls of serum free media (non-supplemented EMEM) for 24 hours. 
Four dishes were then fixed using 4% formaldehyde (Sigma, Poole, Dorset) for 
30mins at room temperature to provide the t=0 reference controls. The remaining 
dishes were placed in experimental conditions the cells were maintained for a further 
3 days. Following this period, the cells were fixed in 4% formaldehyde. The media 
was removed and the cells were stained using Coomassie Brilliant blue G 250 (Merck, 
Germany) protein dye and left at room temperature for 45 minutes. Excess Coomassie 
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blue dye was removed when the dishes were washed with PBS. Images of the patches 
were captured using gene snap software (Syngene, Cambridge, UK) and a CCD 
camera. The patches were then converted to binary images of black and white pixels 
using threshold techniques and measured using Scion Image to determine the number 
of black pixels, which corresponds to the area of cell coverage. To provide additional 
data, total protein was assessed to provide a measure of cell population. This was 
achieved by extraction of Coomassie Blue dye from the cells by addition of 1000µl of 
70% (v/v) ethanol. The dishes were left on a shaker for 1 hour at room temperature. 
100µl from each dish was then sampled and added to a 96 well plate (BD Falcon, 
Oxford, UK). The absorbance was measured at 550nm using a Wallac Victor 2 1420 
plate multi-label counter with Elmer Workout (V15) software (Perkin Elmer, 
Cambridge, UK).  
 
2.4 3H-Thymidine incorporation assay 
One milliliter of a 1 x 104 cells/ml suspension of FHL124 cells in 10% FCS–EMEM 
was added to each well of a 24-well tissue culture plate (Beckton Dickinson labware, 
NJ, USA) and cultured for 48 hr. Following this period the medium was removed and 
replaced with serum free medium (EMEM (Sigma, Poole, Dorset)) and cultured for a 
further 48hrs. This medium was then removed and the cells placed in experimental 
conditions for a further 24hrs. During the final 4hrs of this culture period the cells 
were exposed to 1µci ml-1 3H-thymidine (Amersham, International) and 1µm cold 
thymidine. At the end of culture each well was washed twice with 1ml EMEM 
(Sigma, Poole, Dorset) to remove any radioactive 3H-thymidine. One millilitre of 5% 
trichloroacetic acid (TCA) was added to each well. After 30min at room temperature, 
the TCA was removed and 1ml of 250mM NAOH was added to each well and left 
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overnight at 4ºC, 5ml of this NAOH was then sampled. 10 millilitres of scintillation 
fluid (Perkin Elmer, Cambridge, UK) was added to each sample and then 
measurements were taken using a scintillation counter (EG and G Wallac, UK). 
 
2.5 Capsular Bags 
After the removal of corneo-scleral discs for transplantation purposes, human donor 
eyes obtained from the East Anglian Eye Bank were used to perform sham cataract 
surgery, including continuous circular capsulorhexis (5 or 8 mm), hydroexpression of 
lens fibre mass, and aspiration of residual lens fibres. The capsular bag was then 
dissected free from the zonules and secured on a sterile polymethylmethacrylate Petri 
dish (BD Falcon, Oxford, UK). Six to eight entomological pins (Dl; Watkins and 
Doncaster, Kent, UK) were inserted through the edge of the capsular bag to retain its 
circular shape. Cultures were maintained in 1.5 ml of EMEM (Sigma, Poole, UK) 
supplemented with 10% foetal calf serum and 50 mg/1 gentamicin, and incubation 
was at 35 °C in a 5% CO2 atmosphere. In the current invesitigation one eye from a 
donor was used as a control while one was exposed to 100µM histamine in order to 
limit the affect of biological or age variations between donors. The maintenance 
medium and histamine were replaced every other day. Ongoing observations were 
performed using phase-contrast and dark-field microscopy. 
 
 
2.6 Calcium Imaging 
FHL 124 cells originally seeded at a density of 1x 103 cells/100µl 5% FCS EMEM 
(Sigma, Poole, Dorset) on round glass cover slips (10 mm diameter) were imaged 
within 6 days. On the day of the experiment, cells were loaded with the 
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acetoxymethylester (AM) form of 2µM Fura-2/AM for 60 min at 35°C. The lens cells 
were then washed in artificial aqueous humor (AAH) for 20 min to allow complete 
de-esterification of the dye. The composition of AAH is (in mM): 130 NaCl, 5 KCl, 5 
NaHCO3, 1 CaCl2, 0.5 MgCl2, 5 glucose, and 20 HEPES, adjusted to pH 7.25 with 
NaOH. The coverslip with the dye loaded cells was then placed in an imaging 
chamber which was mounted on the heated stage of an epifluorescence microscope 
(model TE-200; Nikon, Tokyo, Japan) fitted with a x20 objective. The imaging 
chamber with a depth of 3 mm was designed for calcium imaging, in which cells were 
continuously perfused with AAH at 35°C. Solutions were administered by a two-way 
tap using a flow rate of 1 ml/min. Different concentrations of histamine and molecular 
antagonist were added to the chamber through the irrigation tube. Cells were excited 
alternatively with light of 340- and 380-nm wavelengths. The emitted fluorescence 
was detected at 510 nm every 2s. After background subtraction the ratio of the light 
intensity monitored at 340/380 was used as an index for Ca2+ release. A minimum of 
5 cells were analyzed in each experimental condition, and all experiments were 
repeated on three further occasions to give N=4. 
 
 
2.7 Suspended Bead Array (BIOPLEX) Analysis of cytokines and signalling 
molecules 
FHL 124 cells were seeded onto 35-mm dishes at ~30,000 cells in 400l of 5%FCS-
EMEM (Gibco, Invitrogen Ltd, Paisley, UK) and were maintained in 1.5ml of 
5%FCS-EMEM for 3 days. Following a 24 hour incubation period in non-
supplemented EMEM cells were treated with Histamine at 100µM for 0, 2, 5, 10, 30, 
and 60 minutes respectively. At each time-point, the culture medium was removed 
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and stored before cells were lysed using a Bio-Plex Cell Lysis Kit, following 
manufacturers instructions (Bio-Rad, Hercules, CA). Lysates were pre-cleared by 
centrifuging at 4500 rpm at 4°C for 20 minutes. Equal amounts of protein per sample 
from cell lysates were analysed for phosphorylated and total levels of ERK1/2, P38 
and JNK. The culture medium was analysed for cytokine levels. In each case 
commercially available Bio-Plex Suspended Multiplex Bead Array Assay kit (Bio-
Rad) were employed. Data from the reaction was acquired using a Luminex X Map-
100™ instrument and accompanying Bio-Plex Manager™ software (Bio-Rad, 
Hemmel Hempstead, UK). The median fluorescence intensity was used as a measure 
of detection. 
 
2.8 Immuno-cytochemistry 
FHL-124 cells were seeded onto glass cover slips (VWR International, Lutterworth, 
Leicestershire) in 35mm petri dishes (BD Falcon, Oxford, UK) in 100l EMEM 
supplemented with 5% FCS. These were left to grow for 3 days until confluent at 
35˚C/5%CO2 and then transferred to serum free conditions supplemented with 
gentamycin (5g/ml, Sigma) for 24 hours. The experimental conditions were added to 
each dish and they were incubated at 35˚C/5% CO2 for 2 hours. The medium was 
aspirated off and the cells washed with PBS and then fixed with 1.5ml of 4% 
formaldehyde in PBS at room temperature for 30 minutes. The formaldehyde was 
then aspirated off and the cells given three washes with PBS/BSA0.02%/IGEPAL 
0.05%. 1.5ml 0.5%-Triton-x-100 was then added to each dish for 30 minutes at room 
temperature in order to permeabalise the cells followed by another three washes with 
PBS/BSA0.02%/IGEPAL 0.05% for 10 minutes each with shaking. The edges of the 
coverslips were dried carefully with tissue to create surface tension when the solutions 
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were added.  A blocking solution was made up and 40l was added to each dish. A 
small plastic coverslip was placed on top in order to disperse the solution evenly and 
prevent evaporation of the solutions. The dishes were placed in square petri dishes 
with wetted tissue in the base and place in a 35˚C incubator for 1 hour. Forty 
microlitres of anti-pERK (mouse monoclonal antibody) (Cell Signalling Technology, 
Beverly, MA) (1:100 dilution in 1% BSA (Sigma, Poole, Dorset)) was added to the 
coverslips which were incubated at 35˚C for another hour. After an hour the cells 
were washed three times with PBS/BSA0.02%/IGEPAL 0.05% for 15 minutes each 
with shaking. Forty micro litres of ALEXA 488-conjugated anti-mouse secondary 
antibody (Molecular Probes, Leiden, Netherlands) was added and the dishes placed in 
square petri dishes covered in aluminium foil. The cells were left in secondary 
antibody for 1 hour at 35˚C. After the hour the cells were again washed three times 
with PBS/BSA0.02%/IGEPAL 0.05% for 15 minutes each with shaking. A mixture of 
Texas Red-X-phalloidin (Molecular Probes, Leiden, Netherlands) at 1:100 dilution 
with 1% BSA and DAPI (Sigma, Poole, Dorset) at a 1:50 dilution with 1% BSA was 
made up and 40l was added to each coverslip. The cells were further incubated in the 
dark at 35˚C for 10 minutes. These two substances stain for F-actin and chromatin 
respectively allowing the cells and the nuclei to be visualised. A final series of three 
washes with PBS/BSA0.02%/IGEPAL 0.05% at 15 minutes each with shaking is 
given to the cells. To mount the coverslips a drop of hydromount mounting solution 
(National Diagnostics, Atlanta, GA, USA) was added to pre-cleaned slides and the 
coverslips placed cell side down on to the slide. The coverslips were left in the dark at 
room temperature for 20-30 minutes to allow the mounting solution to dry and then 
stored in the dark at 4˚C until imaged. The cells were imaged using a Zeiss 
Fluorescent microscope with an attached digital camera and Axiovision software 
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(Carl Zeiss Ltd, Welwyn Garden City, UK).  
 
2.9 Statistical analysis 
T-test analyses using Excel software (Microsoft, Redmand, WA) and a one way 
ANOVA with Tukey’s post-hoc analysis using SPSS 12.0 for windows (SPSS Inc, 
Illinois) were performed to determine any statistical difference between experimental 
groups. Significance was assessed using a p value of ≤0.05. 
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3. Results 
 
3.1 Gene Array 
 
3.1.1 Analysis of Gene Array Data Derived from Quiescent, Dividing and 
Differentiated Regions of the Human Lens to Identify Genes Associated with 
Histamine 
Gene array analysis was carried out for three distinct regions of the human lens: the 
equator; the central epithelium; the fibres. Using the NCBI website genes associated 
with Histamine were identified and expression levels determined from the array data. 
These genes were categorised by their functional role.  
 
3.1.2 Histamine Receptor Expression 
The levels of the genes encoding four histamine receptors are shown in figure 5. This 
clearly shows that HRH1 is present in the epithelium with similar levels observed in 
the central and equatorial regions (Figure 3.1). However, HRH1 was not detected at a 
significant level in the fibre cell population (Figure 3.1). None of the remaining genes 
encoding histamine receptors (HRH2-4) were detected in the epithelium. Expression 
of HRH2 however was detectable in the fibre cells, albeit at a relatively low level this 
was still significant. 
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3.1.3 Histamine Metabolism and Breakdown 
Histidine decarboxylase (HDC), the gene encoding the primary enzyme responsible 
for histamine synthesis was not detected in any lens region (Figure 3.2). Conversely, 
gene expression of Histamine N-Methyltransferase (HNMT) which is involved in 
histamine breakdown was significantly detected in the central and equatorial 
epithelium; lower expression was observed in the fibre cells but this was still 
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Fig. 3.1. Heat maps of gene expression of genes in three distinct regions of the human lens. 
Specifically histamine receptor gene expression in three distinct regions of the human lens. 
Expression was ascertained following analysis of Illumina gene array data sets. A. The data are 
presented as heat maps showing expression for each donor lens and B. as a bar chart showing pooled 
values (Mean ± SEM) from all four donors.  
A. 
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Fig. 3.2. Heat maps of gene expression of genes in three distinct regions of the human lens. Specifically 
expression of genes regulating histamine synthesis and histamine breakdown in three distinct regions of 
the human lens. Expression was ascertained following analysis of Illumina gene array data sets. A. The 
data are presented as heat maps showing expression for each donor lens and B. as a bar chart showing 
pooled values (Mean ± SEM) from all four donors.  
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significant. Other genes associated with histamine breakdown; Diamine D-amino-acid 
oxidase (DAO) and amiloride binding protein 1 (ABP1) were not detected in any 
region. Amine oxidase, copper containing 2 (AOC2) was not detected in the central 
epithelium or within fibre cells, but was significantly detected in the equatorial cells 
(Figure 3.2).  
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Fig. 3.3. Heat maps of gene expression of genes in three distinct regions of the human lens. 
Specifically expression of genes associated with Histamine signalling regulation in three distinct 
regions of the human lens. Expression was ascertained following analysis of Illumina gene array 
data sets. A. The data are presented as heat maps showing expression for each donor lens and B. as 
a bar chart showing pooled values (Mean ± SEM) from all four donors.  
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Of the histamine signal regulators evaluated, only PRKCD (Protein Kinase C) was 
detected at a significant level. Gastrin, ADRBK, FCER1A and VDR were not 
detected (Figure 3.3). 
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Cytokines that have a well established association with histamine were analysed; 
these include the genes encoding IL3, IL4, IL6, IL8, IL13, and CSF2. Interestingly, 
no message for these cytokines was detected in any regions of the lens (Figure 3.4). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
MAPK3 (ERK1), encoding a secondary messenger in cell signalling, was observed at 
significantly higher levels than other secondary messengers in all regions of the lens 
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Fig. 3.4. Heat maps of gene expression of genes in three distinct regions of the human lens. 
Specifically expression of genes encoding cytokines associate with Histamine in three distinct 
regions of the human lens. Expression was ascertained following analysis of Illumina gene array 
data sets. A. The data are presented as heat maps showing expression for each donor lens and B. 
as a bar chart showing pooled values (Mean ± SEM) from all four donors.  
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Fig. 3.5. Heat maps of gene expression of genes in three distinct regions of the human lens. 
Specifically expression of genes associated with histamine and cell signalling in three distinct 
regions of the human lens. Expression was ascertained following analysis of Illumina gene array 
data sets. A. The data are presented as heat maps showing expression for each donor lens and B. as 
a bar chart showing pooled values (Mean ± SEM) from all four donors.  
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(Figure 3.5). MAPK1(ERK2) and STAT6 were also detected at moderate levels 
compared to other second messengers in all three regions; Detected levels of MAPK1 
were significant in fibre cells relative to the epithelial populations. 
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Three further genes analysed that are associated with the inflammatory response, 
namely von Willebrand factor (VWF), Defensin beta 4 (DEFB4) and prostaglandin-
endoperoxide synthase 2 (PTGS2) were studied (Figure 3.6). Of these three, only 
VWF was detectable in the lens; however levels were relatively low and only 
significant in the equatorial region.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
CTNNB1 (Catenin) encodes a protein that forms adherin junctions and anchors the 
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Fig. 3.6. Heat maps of gene expression of genes in three distinct regions of the human lens. Specifically 
expression of genes associated with an inflammatory response and histamine in three distinct regions of 
the human lens. Expression was ascertained following analysis of Illumina gene array data sets. A. The 
data are presented as heat maps showing expression for each donor lens and B. as a bar chart showing 
pooled values (Mean ± SEM) from all four donors. 
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cytoskeleton. It was detected at significant levels in all regions of the lens with very 
little difference in the expression pattern between these regions (Figure 3.7). 
Significantly high expression levels of LASP1, encoding an actin binding protein, 
were observed in the central epithelium and equatorial regions; expression in the fibre 
cells was lower but still significant. PPP1R14A, encoding a smooth muscle myosin 
phosphatase inhibitor, was detected at significantly higher levels in the fibre cells 
compared with the other two regions where it was detected at relatively low levels 
(Figure 3.7). 
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Fig. 3.7. Heat maps of gene expression of genes in three distinct regions of the human lens.  Specifically 
expression of genes associated with cellular junctions, cytoskeleton that are linked to histamine regulation 
in three distinct regions of the human lens. Expression was ascertained following analysis of Illumina 
gene array data sets. A. The data are presented as heat maps showing expression for each donor lens and 
B. as a bar chart showing pooled values (Mean ± SEM) from all four donors.  
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Cell Receptors that are activated by histamine induced mediators were also assessed. 
No significant level of expression was detected for any of these genes. GABRB3 was 
the only gene showing an indication of expression, but this was not significant (Figure 
3.8). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
3.1.4 Inhibitors and Inducers of Histamine Release 
All the inhibitors analysed were not detected at significant levels in any region of the 
lens (Figure 3.9).  
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Fig. 3.8. Heat maps of gene expression of genes in three distinct regions of the human lens. All the 
genes were expressed at low levels in all three regions of the lens. Expression of genes and gene 
fragments encoding receptors influenced by Histamine, in three distinct regions of the human lens. 
Expression was ascertained following analysis of Illumina gene array data sets. A. The data are 
presented as heat maps showing expression for each donor lens and B. as a bar chart showing pooled 
values (Mean ± SEM) from all four donors.  
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In contrast the inducers of histamine release were detected at significant levels. 
Tumour protein translational controlled 1 also known as histamine releasing factor 
(TPT1 or HRF) was detected at significantly high levels in all three regions of the 
lens. ABL1, a tyrosine kinase receptor, was also detected at significant levels in 
epithelial regions but not the fibre cells. SYK, another tyrosine kinase, was observed at 
in the central epithelium at a higher level than in the equatorial region, but not 
significantly, and was not detected in the fibre cells. BCR was only observed at 
significant levels in the central epithelium and only detected at low levels in the 
equatorial region and fibre cells (Figure 3.10). 
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Fig. 3.9. Heat maps of gene expression of genes in three distinct regions of the human lens. 
Specifically expression of gene fragments associated with the inhibition of Histamine release, in 
three distinct regions of the human lens. Expression was ascertained following analysis of 
Illumina gene array data sets. A. The data are presented as heat maps showing expression for 
each donor lens and B. as a bar chart showing pooled values (Mean ± SEM) from all four 
donors.  
 
A. 
B. 
 45 
 
0
50
00
10
00
0
15
00
0
20
00
0
25
00
0
BC
R
BC
R
BC
R
AB
L1
AB
L1
AB
L1
AB
L2
AB
L2
AB
L2
SY
K
TA
AR
6
TP
T1
LIL
RA
2
NG
FB
Ge
n
e
Gene Expression (AU)
Ce
nt
ra
l E
pit
he
liu
m
Eq
ua
to
r
Fi
br
e 
Ce
lls
0
20
0
40
0
60
0
80
0
10
00
12
00
14
00
BC
R
BC
R
BC
R
AB
L1
AB
L1
AB
L1
AB
L2
AB
L2
AB
L2
SY
K
TA
AR
6
LIL
RA
2
NG
FB
Ge
ne
Gene Expression (AU)
Ce
nt
ra
l E
pit
he
liu
m
Eq
ua
to
r
Fi
br
e 
Ce
lls
 
 
 
TP
T1
LI
LR
A
2
N
G
FB
TP
T1
LI
LR
A
2
N
G
FB
TP
T1
LI
LR
A
2
N
G
FB
Ce
n
tra
l E
pi
th
e
liu
m
D
o
n
o
r
1 2 3 4
G
e
n
e
B
CR
B
C
R
B
CR
A
B
L1
A
B
L1
A
B
L1
A
B
L2
A
B
L2
A
B
L2
S
Y
K
TA
A
R
6
Pr
o
be
 
1
Pr
o
be
 
2
Pr
o
be
 
3
Pr
o
be
 
1
Pr
o
be
 
2
Pr
o
be
 
3
Pr
o
be
 
1
Pr
o
be
 
2
Pr
o
be
 
3
E
qu
a
to
r
D
o
n
o
r
1 2 3 4
G
e
n
e
B
CR
B
C
R
B
CR
A
B
L1
A
B
L1
A
B
L1
A
B
L2
A
B
L2
A
B
L2
S
Y
K
TA
A
R
6
Pr
o
be
 
1
Pr
o
be
 
2
Pr
o
be
 
3
Pr
o
be
 
1
Pr
o
be
 
2
Pr
o
be
 
3
Pr
o
be
 
1
Pr
o
be
 
2
Pr
o
be
 
3
Fi
br
e
D
o
n
o
r
1 2 3 4
G
e
n
e
B
CR
B
C
R
B
CR
A
B
L1
A
B
L1
A
B
L1
A
B
L2
A
B
L2
A
B
L2
S
Y
K
TA
A
R
6
Pr
o
be
 
1
Pr
o
be
 
2
Pr
o
be
 
3
Pr
o
be
 
1
Pr
o
be
 
2
Pr
o
be
 
3
Pr
o
be
 
1
Pr
o
be
 
2
Pr
o
be
 
3
Fi
g.
 
3.
10
.
 
H
ea
t m
ap
s 
o
f g
en
e 
ex
pr
es
sio
n
 
o
f g
en
es
 
in
 
th
re
e 
di
st
in
ct
 
re
gi
o
n
s 
o
f t
he
 
hu
m
an
 
le
n
s.
 
Ex
pr
es
sio
n
 
w
as
 
as
ce
rt
ai
n
ed
 
fo
llo
w
in
g 
an
al
ys
is 
o
f I
llu
m
in
a 
ge
n
e 
ar
ra
y 
da
ta
 
se
ts
.
 
.
 
A
.
 
Th
e 
da
ta
 
ar
e 
pr
es
en
te
d 
as
 
he
at
 
m
ap
s 
sh
o
w
in
g 
ex
pr
es
sio
n
 
fo
r 
ea
ch
 
do
n
o
r 
le
n
s 
an
d 
B.
 
as
 
a 
ba
r 
ch
ar
t 
sh
o
w
in
g 
po
o
le
d 
v
al
u
es
 
in
cl
u
di
n
g 
TP
T1
 
an
d 
C
.
 
a 
ba
r 
ch
ar
t n
o
t c
o
n
ta
in
in
g 
TP
T1
.
 
(M
ea
n
 
±
 
SE
M
) f
ro
m
 
al
l f
o
u
r 
do
n
o
rs
.
 
 
B.
 
C
.
 
G
en
e 
Ex
pr
es
si
on
 
(A
U)
Co
lo
ur
<
50 50
-
10
0
10
0-
20
0
20
0-
40
0
40
0-
80
0
80
0-
16
00
16
00
-
32
00
32
00
-
64
00
>
64
00
A
.
 
 46 
 
0
500
1000
1500
2000
2500
CHEK1 CDC25B CDC25B CDC25C CDC2
Gene
G
en
e 
Ex
pr
e
s
s
io
n
 
(A
U
)
Central Epithelium
Equator
Fibre Cells
CDC25B was detected at significantly high levels in both the central epithelium and 
equatorial region  (Figure 3.11). It was also detected at lower levels in the fibre cells 
but this was still significant. No other gene associated with cell cycle control was 
detected at a significant level, though CDC25C was detected at in the fibre cells albeit 
at a very low level (Figure 3.11). 
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Fig. 3.11. Heat maps of gene expression of genes in three distinct regions of the human lens. 
Specifically expression of genes associated with histamine and cell cycle control in three distinct 
regions of the human lens. Expression was ascertained following analysis of Illumina gene array 
data sets. A. The data are presented as heat maps showing expression for each donor lens and B. as a 
bar chart showing pooled values (Mean ± SEM) from all four donors.  
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Selected genes were used to show that the samples for each region are pure samples. 
When the samples for each region were analysed the expected pattern of expression 
was observed (Figure 3.12).  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 Fig. 3.12.  Heat maps of the expression of genes. Expression of gene markers of lens cells in 3 
regions of the human lens demonstrate . Expression was ascertained following analysis of 
Illumina gene array data sets. A. The data are presented as heat maps showing expression for 
each donor lens and B. as a bar chart showing pooled values (Mean ± SEM) from all four 
donors.  
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3.2 Growth 
 
3.2.1 Histamine Induced Growth of FHL 124 Cells 
Data obtained from patch growth assays revealed a concentration-dependent growth 
of FHL 124 cells in response to histamine. A promotion of growth was observed 
following addition of 100µM histamine, such that a 15.2 ± 5.8% increase in cell 
population was detected (Figure 3.13). Moreover, 100µM histamine also increased 
patch area by 12.4 ± 6% relative to the serum free control (Figure 3.14).  To provide a 
more sensitive evaluation of histamine effects on cell proliferation, the 3H thymidine 
incorporation assays were employed. Using this system, the data again show a 
concentration-dependent response to histamine (Figure 3.15). Significant effects on 
proliferation were observed following the application of 30 or 100µM, such that 
observed levels were 155.2 ± 7.6% and 164.9 ± 14.1% respectively when compared to 
serum free controls.  
 
 
 
 
 
 
 
 
 
 
Fig. 3.13. Cell population determined by total protein levels following a 72 hour incubation 
period in the presence of 1, 10 and 100uM Histamine. There were no significant changes in cell 
population but there is a general trend that dye absorbance increases with histamine 
concentration. (N=11) 
 
 49 
 
0
20
40
60
80
100
120
140
SF 1 10 100
Histamine Concentration (uM)
Pa
tc
h 
A
re
a
 
(%
 
Co
n
tr
o
l)
 
 
 
 
 
 
 
0
20
40
60
80
100
120
140
160
180
200
0 1 3 10 30 100
Histamine Concentration (uM)
3-
H 
Th
ym
id
in
e 
Le
v
el
 
(%
 
co
n
tr
o
l)
 
 
3.2.2 Histamine Induced Growth is Histamine Receptor 1 Dependent 
Cells maintained in the presence of 30µM histamine showed an increase in both cell 
population and patch area relative to the control group that were 45.1 ± 4.77% and 
11.93 ± 3.32% respectively (Figure 3.16). Cells maintained in the Histamine receptor 
1 antagonist, triprolidine at 100µM had a similar cell population and patch area to the 
Fig. 3.14. Cell growth/coverage assessed by changes in cell patch area following a 72 hour 
incubation period in the presence of 1, 10 and 100uM Histamine. There were no significant 
changes in cell population but there is a general trend that dye absorbance increases with 
histamine concentration. (N=11) 
 
Fig. 3.15. 3H-Thymidine levels in FHL-124 cells, as percentage of control, following incubation 
with 0, 1, 3, 10, 30 and 100uM Histamine. There was a significant increase in 3H Thymidine 
levels when FHL-124 cells were incubated with 30 and 100uM Histamine. The other 
concentrations showed a dose dependant increase over control levels but were not significant 
increases.  Data are expressed as mean ± SEM, n = 3. * indicates a significant difference between 
treated group and baseline (ANOVA with Dunnett’s post-hoc analysis, p ≤ 0.05). 
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serum free control. Cells maintained in the presence of 100µM triprolidine and 30µM 
histamine had cell populations and patch area that significantly differed from the 
histamine treated group (Figure 3.16). Therefore, triprolidine suppressed the 
histamine induced response.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
3.2.3 Histamine Induced Cell Growth on Capsular Bags  
Two sets of matched capsular bags were prepared as described in the methods section. 
One capsular bag was maintained in serum-free medium and the other supplemented 
A. 
B. 
* 
* 
Fig. 3.16. HRH1 dependent histamine induced growth. (A) Cell population determined by 
total protein level and (B) growth assessed by changes in patch area in response to 30µM 
histamine in presence and absence of 100µM triprolidine. Data are expressed as mean ± 
SEM, n = 4. * indicates a significant difference between control cells and corresponding 
triprolidine treated group (ANOVA with Tukey’s post-hoc analysis, p ≤ 0.05). 
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Fig. 3.17. A Low-power modified dark field images of capsular bags immediately following 
preparation and following 14 days of culture in the presence or absence of 100µM histamine. B 
The progression of growth across the posterior capsule of the illustrated preparations is presented 
above. This experiment was repeated on one further occasion and produced similar results.  
with100µM histamine. The preparations from different donors grew at different rates; 
however in both cases the capsular bag maintained in 100µM histamine covered the 
posterior capsule faster than the match-paired control (Figure 3.17).  
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3.3 Intracellular signalling 
 
3.3.1 Histamine Induced Calcium Signalling is Mediated through H1 Receptors 
No significant change in baseline intracellular calcium concentration was observed 
with 0.1µM histamine. Addition of histamine at 1µM and above showed a 
concentration dependant release of calcium from the intracellular store of FHL-124 
cells (Figure 3.18).   
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Fig. 3.18. Histamine modulates calcium mobilisation in FHL 124 cells in a concentration 
dependent manner.  A. A typical trace, showing an incremental increase in the ratio of signal 
following excitation of FURA2 at 340 and 380nm; an increase in ratio corresponds to elevated 
intracellular calcium level. B. Pooled data showing the relative calcium response at different 
histamine concentrations; data are expressed as mean ± SEM, n = 4. * indicates a significant 
difference between treated group and baseline (ANOVA with Dunnett’s post-hoc analysis, p ≤ 
0.05). 
 53 
 
0.000
0.100
0.200
0.300
0.400
0.500
0.600
1 51 101 151 201 251 301 351 401
Time point
Ra
tio
 
34
0n
m
-
38
0n
m
100uM 100uM 100uM  
Histamine 
100uM 
0
20
40
60
80
100
120
HRH1 antagonist
(Triprolidine)
HRH2 antagonist
(Rantidine)
HRH3 antagonist
(Thiopermide)
Treatment
%
 
In
hi
bi
tio
n
 
o
f h
is
ta
m
in
e
 
re
s
po
n
s
e
Fig. 3.19. Characterisation of histamine induced calcium mobilisation in FHL 124 cells. (A) Pre-
incubation with the HRH1 antagonist Triprolidine (100µM), caused total inhibition of the 
histamine-induced response. Pre-incubation with HRH2 or HRH 3 antagonists did not significantly 
perturb histamine induced calcium mobilisation (data not shown). 100uM ATP was added to 
demonstrate that the calcium store was unaffected by the antagonists. (B) Pooled data showing the 
ability of HRH antagonists to inhibit a 100µM histamine induced calcium response. Data are 
expressed as SEM, n≥3. * indicates a significant difference between antagonist treated group and 
histamine treated control (students t-test, p ≤ 0.05). 
 
 
To determine which histamine receptors were responsible for the calcium response, 
molecular antagonists for the three main groups of histamine receptor were used 
(Figure 23). Pre-treatment with 100µM triprolidine, an HRH1 antagonist, completely 
negated calcium release typically associated with 100µM histamine  When 100µM 
histamine was added following pre-treatment with 100µM Ranitidine, an HRH2 
antagonist, or 10µM Thioperamide, an HRH3 antagonist, no significant inhibition was 
observed (Figure 3.19). 
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3.3.2 Histamine Activates Additional Signalling Pathways   
A time course was performed to see the effects of 100µM histamine upon the 
expression of three signalling molecules using BIOplex analysis (Figure 3.20). The 
levels of phosphorylated P38 (p-P38) were seen to increase within minutes of 
histamine addition and continued to rise until levels peaked at the 10 minute time-
point before gradually decreasing and returning  to baseline one hour following initial 
stimulation (Figure 3.20). A similar sequence of events was observed with pERK 
levels and to a lesser extent pJNK. Peak values for p-P38 and pERK were significant 
relative to unstimulated controls, such that the change in level was 2.1 and 2.6 fold 
respectively (Figure 3.20). While pJNK in response to histamine was elevated 3.1 fold 
of control this was not significant due to variability in response (Figure 3.20).  
 
3.3.3 ERK Mobilisation in Response to Histamine 
Immunocytochemistry was used to evaluate the distribution of pERK following 
application of 100µM histamine (Figure 3.21). Following 5 minutes exposure to 
histamine a clear localisation of pERK is observed in the nucleus of FHL-124 cells. 
At the 10 minute time-point significant levels of pERK can be observed, which 
appears to be largely cytoplasmic in distribution. The level of pERK then 
progressively declines, such that levels are similar to unstimulated controls following 
60 minute incubation. This pattern is similar to that seen in the BIOplex data for p-
ERK. 
 
3.3.4 Histamine Regulation of Cytokine Release. 
The relative protein level of cytokines in FHL-124 cells were analysed using BIOplex 
suspended bead array analysis (Figure 3.22). This included a large number of 
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Fig. 3.20. Histamine-induced signaling detected by suspended bead array assay. Changes in 
phosphorylation levels of (A) P38, (B) ERK1/2, and (C) JNK in response to 100µM histamine 
were detected over a 1-hour period. The data represent mean ±SEM, n = 4 normalized to the 
corresponding total of ERK1/2, P38, and JNK for each sample respectively. (D) Mean 
phosphorylation levels at the 10 minute time point for the three target proteins. *Significant 
difference between histamine-treated and unstimulated control (P ≤ 0.05, 1 tailed t-test). 
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Fig. 3.21. Fluorescent micrographs showing p-ERK (Green) distribution in FHL-124 cells following exposure 
to 100uM Histamine. The actin (red) and chromatin (blue) stains are counterstained to show the 
cytoskeleton/overall cell shape and nuclear region of the cells respectively. This experiment was repeated on 
two further occasions with similar results obtained. The image represents a field of view 139 x 114µm. 
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interleukins which are involved in inflammatory responses.  The overall profile of 
interleukins expressed was not changed by the addition of 100µM histamine as no 
new interleukins were expressed and none were inhibited compared with serum free 
controls (Figure 3.22). However, interleukins IL-6 and IL-8 showed a significant 
increase in expression when cells were maintained in the presence of 100µM 
histamine compared to the serum free control (Figure 3.22). A change in expression 
pattern was also observed with the other cytokines analysed. Granulocyte macrophage 
colony-stimulating factor (GM-CSF), Tumour necrosis factor- alpha (TNF-α), and 
eotaxin were all expressed in serum free conditions but were then not detected 
following exposure to 100µM histamine (Figure 3.22). Platelet-derived Growth 
Factor-BB (PDGF-bb) was not detected in serum free conditions but was detected in 
response to 100µM histamine addition. Macrophage Inflammatory Protein-1 beta 
(MIP-1b) and fibroblast growth factor (FGF) showed decreases from the serum free 
levels when in the 100µM histamine conditions though not significant. Monocyte 
chemotactic protein-1 (MCP-1), interferon-inducible protein 10 (IP-10), Macrophage 
Inflammatory Protein- 1 alpha (MIP-1a), regulated upon activation, normal T cell 
expressed and secreted (RANTES), and Vascular endothelial growth factor (VEGF) 
all showed increase when in 100µM histamine conditions though none were 
significant increases (Figure 3.22). 
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4. Discussion 
 
The current project revealed a number of interesting findings that have furthered our 
knowledge of histamine regulation of the human lens. The normal human lens does 
not express the machinery to synthesise histamine, but demonstrates high levels of 
releasing factors and histamine receptor. Stimulation of lens cells with histamine 
promotes multiple signalling pathways and increases growth rate. This information 
has relevance to the homeostasis of the normal lens and progression of lens 
pathologies. 
 
4.1 Histamine and the Normal Function of the Lens 
Gene array analysis of three regions in a normal clear lens was extremely informative. 
This gave insight into the possible functions for histamine in the lens by seeing which 
genes were expressed and importantly those that were not.  
 
4.1.1 The Lens Can Respond to and Break Down Histamine but Does Not Contribute 
to the Histamine Stored within the Eye  
If histamine is to play a role in the normal lens it is imperative that it can respond to 
the stimuli if available and with this regard HRH1 was detected in the lens epithelial 
cell compartments. This concurs with previous studies on the lens, which 
demonstrated a H1 receptor dependent calcium response in the native human lens {R. 
A. Riach, 1995 #6}. However, the current data suggest that histamine elicits all its 
actions through this receptor as HRH2-4 receptors were not detectable. HRH1 has 
primary roles in inducing smooth muscle contraction and mediating inflammatory 
responses but can promote a wide number of additional cell functions, which include 
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migration and proliferation typically through mobilisation of intracellular calcium 
stores {Hill, 1990 #11}{S. J. Hill, 1997 #44}{Stark, 2007 #45}. 
 
As the lens has the ability to respond to histamine signalling it is logical that 
breakdown systems are present to regulate the level of signalling. With regards to this 
the lens expresses histamine N-methyltransferase (HNMT) in all three regions and 
Amine oxidase, copper containing 2 (AOC2) in the equatorial region.  
 
The lens however is unlikely to contribute to the histamine pool within the eye. This 
is perhaps predictable as histamine is traditionally stored in specialised cells such as 
mast cells that are not located within the lens {M. E. Parsons, 2006 #54}. 
Nevertheless the array data confirm this as histidine decarboxylase (HDC), the gene 
involved in histamine production, was not detected.  Therefore, if histamine is to 
stimulate the lens it must become available through non-lenticular sources, many of 
which are known to exist in the eye. The Iris and choroidal tissue for example both 
contain mast cells and can store histamine {McMenamin, 1997 #55}{May, 1999 #34} 
{T. Nakagami, 1999 #35}. There are also conditions such as uveitis and pterygia 
when normal histamine function alters leading to eye pathologies. {N. Girolamoa, 
2004 #15} {C. H. Lee, 1993 #56} 
 
The most widely understood process for histamine release in the eye is as a 
consequence of an inflammatory response. It is reported that a release of histamine is 
required to initiate uveitis, a chronic inflammation of the eye, {K. Yamashiro, 2001 
#57} and is also implicated in conditions such as pterygium {R. Maini, 2002 #60}. 
However, it is interesting to note that the eye is not generally inflamed and thus 
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sources of histamine are present within the eye at all times and not just during 
pathological states. It is therefore possible that histamine plays a role in the normal 
functioning of the eye and histamine is regulated and released through processes other 
than an inflammatory cascade; processes that are not well understood. One possible 
regulator of histamine in the eye is histamine releasing factor, which is encoded by 
the gene TPT1. 
 
TPT1, also known as histamine releasing factor (HRF), is expressed at very high level 
in all three regions of the lens. HRF was first discovered as a promoter of tumour 
growth in mice and no other function was found at that point. It has since been shown 
to be a heat shock protein and have anti-apoptotic properties. It is now known to be 
ubiquitously expressed with both intracellular and extra cellular functions. It was also  
discovered that HRF was identical to proteins that had histamine releasing properties 
{U. Bommer, 2004 #40}. Its ability to cause histamine release from mast cells and 
basophils has been widely investigated and were originally thought to be Ig-E 
dependent but further research has given weight to the argument that HRF mediates 
responses independently of Ig-E independent properties {J. M. Langdon, 2004 #18} 
{J. M. Langdon, 2008 #19}. It can also induce the release of several cytokines from 
basophils, T-cells and B-cells {U. Bommer, 2004 #40}. These cytokines can then 
prime basophils for histamine release through phosphorylation of several signalling 
molecules. The properties of histamine release from basophils in humans changes 
depending on the sub population of basophil donors. To the extent that individuals 
with allergic disorders have different molecular properties than those that don’t {B. 
M. Vonakis, 2008 #20}.  
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HRF has been demonstrated to release histamine from multiple cell types found 
within different tissues of the eye {S. M. MacDonald, 1995 #58} {B. M. Vonakis, 
2008 #20} {J. M. Langdon, 2008 #19}. If the HRF released from the lens can reach 
the histamine stores in surrounding tissue, such as the ciliary body and iris, then 
histamine could be released into the aqueous humour and be available to the lens. If 
this mechanism does exist then it opens up the question of why histamine is regulated 
in this way and what function does histamine play in the normal lens and surrounding 
tissue? 
 
The lens is often put under mechanical stress to change the refractive power during 
the process of accommodation. Accommodation is characterised by changes in lens 
shape in order to focus on objects at different distances. It is not beyond the realms of 
possibility that mechanical events can cause the release of HRF into the surrounding 
tissue such as the iris where there are mast cells and basophils {May, 1999 #34}. The 
HRF would induce the release of histamine from these cells into the surrounding 
tissue including the lens. The cells in the lens would then respond to histamine 
through the HRH1 receptor inducing cellular changes that allow the lens cells to 
respond to mechanical stimulation. As the lens has to change its shape from a rounder 
to flatter configuration or vice versa during accommodation it also has to change its 
volume and therefore fluids have to be able to leave and re-enter the lens {R. 
Gerometta, 2007 #33}. Histamine could therefore play a role in changing the osmotic 
potential of the aqueous humour causing changes in fluid flow of the lens. 
Antihistamines cause side effects such as blurred vision especially of distance 
focusing {Pearson, 1950 #10} {J. M. White, 1988 #39}. However, it is not fully 
understood how antihistamines cause blurred vision but the fact that it does lends 
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support to the idea that histamine plays a role somewhere within the visual axis. One 
possibility is that changes in lens hydration cause the lens to thicken {M. A. Spiteri, 
1983 #17}. This may result because histamine is reported to affect vascular 
permeability {G. Majno, 1961 #59} and therefore could play a role in changes to 
osmotic potential of the surrounding aqueous and vitreous humours and thus influence 
a number of tissues including the lens.  However, the current body of data allows us to 
speculate that anti-histamine drugs could have direct actions on the lens that could 
influence accommodative change. This theory however, would require a number of 
questions to be answered to provide supporting evidence. These questions include: 
Can HRF be released from the lens in response to mechanical stimulation? If HRF is 
released can this cause histamine release from local ocular tissues e.g. ciliary or iris? 
What are the diffusion rates following histamine release from ciliary and iris? What 
level of histamine is predicted to become available to lens cells following release? 
 
HRF can perform a number of biological roles; however its close association to 
histamine, the presence of histamine sources in the eye and the lens ability to respond 
to histamine make for an interesting model for histamine regulation of the lens. 
 
4.1.2 Other genes associated with histamine in the normal lens 
The gene array analysis also flagged up many genes associated with histamine with a 
wide range of functions. These included genes for cytokines that are involved in the 
inflammation cascade, genes encoding proteins involved with the cytoskeleton, cell-
cell interactions and cell cycle control. The expression or lack of expression of these 
genes does not give a huge amount of information on its own. They do however give 
an idea of the areas that should be investigated further. The genes for the histamine 
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receptors immediately show that HRH1 is the most likely receptor to be responsible 
for the functions of histamine within the lens. HRH1 has also been shown to be the 
main receptor in the native human lens and that it invokes a calcium response {R. A. 
Riach, 1995 #6}. This means that histamine can initiate downstream responses 
through calcium signalling as HRH1 is a G-protein coupled receptor that causes a 
release of intra-cellular calcium {Stark, 2007 #45} {S. J. Hill, 1997 #44}. However 
other signalling pathways such as the MAP kinase pathway and the STAT pathway 
are also linked with histamine {A. J. Robinson, 2001 #61} {Lipnik-Stangelj, 2006 
#62} {F. Hao, 2008 #14}, though this has not been previously demonstrated in the 
lens. This means that any response resulting from histamine stimulation is likely to 
involve cross talk between signalling pathways. This is supported by the fact that 
calcium signalling has been demonstrated many times to be able to activate a wide 
range of signalling pathways {M. J. Berridge, 2000 #3}. Regional differences across 
the lens epithelium have suggested this is possible. Histamine stimulates the human 
lens at both the central and equatorial region with similar potency {D. J. Collison, 
2001 #68} when using calcium mobilisation as the output. However, other studies {J. 
M. Maidment, 2004 #69} revealed differences in ERK level between the two regions. 
Therefore, activation of different signalling pathways by histamine in different 
compartments of the lens could in turn elicit different functions, such as cell migration 
and proliferation. 
 
The normal lens has the capacity to respond to histamine and it is interesting to 
consider an active role in the homeostasis and function of the lens. However, at 
present such ideas are formative and speculative requiring further experiments to test 
these concepts. There is little doubt, however, that histamine is available to the lens 
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during inflammation and under these circumstances is likely to affect the function of 
lens cells.  
 
Inflammation is an important stage in the immune response but can be very damaging 
to the tissue/organ it is triggered in {P. M. Henson, 1987 #70} {Nathan, 2002 #71}. 
This would be particularly dangerous in the eye as it is an intricate structure where the 
smallest amount of damage to the visual axis can be detrimental to vision. This is why 
the eye has what is known as ocular immune privilege {Streilein, 2003 #36}. This 
means that the eye contains a different immunological environment to that of other 
organs of the body. This privilege takes the form of blood-tissue barriers, a lack of 
lymphatic drainage and tolerance-promoting Antigen-presenting cells. All this is a 
trade off so that the eye may have less ability to fight off infection or tumours but 
there is less chance of an autoimmune or allergic response damaging the eye 
{Streilein, 1996 #72}. When it comes to ocular immune privilege there has been little 
research on the consequences of histamine stimulation in the lens.  
 
 
4.2 Histamine and pathologies 
The current study demonstrates that histamine can induce a significant increase in 
growth rate of lens cells. While this may have implications for growth in the normal 
lens, it is also likely to play an important role in progression of PCO. Histamine is 
likely to be available to lens cells following the ocular immune privilege response 
following cataract surgery and therefore the observed responses are likely to play out 
in vivo. This is the first study to demonstrate that histamine can promote growth of 
human lens cells. A previous study using the rabbit lens cell line NN1003A did not 
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demonstrate a stimulation of growth in response to histamine {G. Duncan, 1996 #73}. 
This contrasting outcome however could result from species differences, which could 
involve the level of histamine receptors, the histamine receptor sub-type or the 
activation of different signalling pathways. The influence on growth by histamine has 
been reported in non-lenticular cells and tissues. For example, Leonardi et al 
demonstrated that proliferation of sub-conjunctival fibroblasts, from Vernal 
Keratoconjunctivitus patients, was promoted by histamine and this was regulated by 
HRH1 {A. Leonardi, 1999 #74}. Again, in the present study, HRH1 was found to be 
the key receptor mediator. 
 
 
4.2.1 Histamine Induced Signalling 
It has already been shown that histamine can induce calcium mobilisation in human 
native lens cells {D. J. Collison, 2001 #68} {R. A. Riach, 1995 #6}. Therefore it was 
logical to determine the effect of histamine on calcium mobilisation within the FHL 
124 cell line. A concentration-dependant response to histamine was observed with a 
peak calcium response between 30µM and 100µM. The response pattern observed in 
the cell line was comparable to the cells of the native human lens. In general, we can 
observe histamine responses in the cell line and native lens. However, it did appear 
that the cell line was approximately 10 fold less sensitive to histamine than the native 
tissue {R. A. Riach, 1995 #6}.  Nevertheless, this is an important validation of the use 
of the FHL-124 cell line in making comparisons to the native human lens and making 
predictions from in vitro results to processes that occur in the normal and pathological 
lens. It will be of great interest in the future to determine sensitivity to histamine of 
cells growing on the lens capsular bag, which would serve as a model of PCO. The 
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gene array data showed that the histamine receptor HRH1 was by far the most highly 
expressed in lens cells. This receptor is therefore the most likely to mediate this 
histamine induced calcium response and any possible downstream cellular functions. 
This was validated, when Triprolidine, a selective HRH1 antagonist was shown to 
ablate the calcium response from 100µM histamine. Calcium signalling has been 
shown to play a key role in cell survival and growth of lens cells {G. Duncan, 1997 
#53} {G. Duncan, 1999 #75} {L. Wang, 2005 #76}. Application of the Ca ATPase 
inhibitor thapsigargin depletes the ER calcium store and suppresses calcium 
signalling. Using this method to disrupt calcium signalling reduced proliferation 
detected using 3H thymidine incorporation of both NN1003A {G. Duncan, 1996 #73} 
rabbit lens epithelial cells and FHL 124 human lens epithelial cells {L. Wang, 2005 
#77}.  
 
It is apparent from a number of studies that histamine can also invoke a number of 
signalling pathways in addition to classical calcium signalling {Lipnik-Stangelj, 2006 
#62} {F. Hao, 2008 #14} {A. J. Robinson, 2001 #61}. Therefore it was important to 
determine if this were true in the lens. Using the suspended bead array method (BIO-
PLEX) histamine was shown to phosphorylate P38 and ERK relative to unstimulated 
controls; however JNK was not altered to a significant degree despite showing a 
similar expression profile. These three molecules represent proteins from the three 
known mammalian MAP kinase pathways {M. J. Robinson, 1997 #63} {G. 
L.Johnson, 2002 #64}. The change in MAPK pathways secondary messengers shows 
that histamine is able to induce multiple pathways. Signalling through these pathways 
will have an effect on gene expression and may also play a role in histamine induced 
growth and other as yet undetermined cellular outputs. P38 MAP kinase cascades 
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have been shown to have a wide array of functions in the immune system but also in 
stress response signalling. It has also been shown to mediator cell proliferation and 
apoptosis {Martin-Blanco, 2000 #37}. JNK MAPK signalling pathways are known to 
be activated by cytokines and in response to environmental stress. They are also 
known to play roles in cell proliferation and apoptosis {Davis, 2000 #30} {C. R. 
Weston, 2002 #31}. ERK MAPK signalling pathways were the first to be discovered 
and also play roles in cell proliferation and apoptosis {C. Peyssonnaux, 2001 #7} {M. 
M. McKay, 2007 #8}. Previous work has shown that lens cell growth can be inhibited 
by disruption of the ras-raf-MEK-ERK pathway using the MEK inhibitor U0126. 
When applied to a human capsular bag, a marked inhibition but not ablation was seen 
{J. M. Maidment, 2004 #69}. Activation of ERK is therefore an important signalling 
mechanism for lens cells and histamines is likely to influence growth through this 
system  
 
Therefore, once it was determined that histamine could induce a calcium response that 
was caused through HRH1 and in addition stimulate MAPK signalling pathways, it 
was logical to test whether this receptor regulated proliferation. If histamine induced 
proliferation was prevented through the use of an HRH1 antagonist then it would be 
known that histamine induced proliferation through HRH1 receptor signalling should 
be a key area of future investigation. Using this approach, it was found that HRH1 
was indeed responsible for growth.  As the MAPK pathways studied are known to 
induce cell proliferation a selective analysis of their role in histamine induced lens 
cell proliferation is merited. This could be tested by application of specific inhibitors 
of each pathway individually in FHL-124 cells in the presence of histamine. This 
would be best done with the more sensitive 3H-thymidine insertion assay. If any of 
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the inhibitors block growth then it will prove that it is that signalling pathway that is 
inducing proliferation. However, if none of the antagonists are shown to block growth 
then a combination of antagonists would need to be used. It could be that all three 
pathways are required to elicit a growth response or that two of them do. Therefore to 
find out which pathways do and which don’t different combinations may need to be 
used. This would involve using two antagonists and not the other. If there is still a 
growth response after using all three antagonists then these pathways will be shown 
not to be involved in histamine induced growth. Another interesting experiment 
would be to use an inhibitor of calcium signalling Such as thapsigargin. If it can be 
shown that growth is caused while calcium signalling is inhibited then the Histamine 
must be inducing growth through a different pathway directly rather than through the 
mobilisation of intracellular calcium. 
 
 
 
4.2.2 Histamine causes a change in cytokine expression in FHL-124 cells 
Having established a number of signalling pathways in the lens that are activated by 
histamine and a growth function, the involvement of histamine in regulating cytokine 
expression was investigated using suspended bead array methods (BIO-PLEX). These 
studies revealed an ability of histamine to alter interleukin expression, which could 
contribute to the functional responses observed with histamine stimulation. Histamine 
is known to cause the release/production of a wide variety of cytokines, which are 
often associated with inflammation, from a number of different cell types {A. 
Mazzoni, 2001 #78} {M. Matsubaraa, 2005 #79} {J. Sirois, 2000 #80} {Falus, 1993 
#66}. A Number of cytokines were identified in the gene array analysis to be linked 
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with histamine. A significant increase in the levels of IL-6, IL-8 and IL-13 was 
observed in response to histamine. IL-8 has been shown to cause cell migration and 
proliferation in a number of cell lines. IL-8 caused migration and proliferation in a 
cancer cell line through ‘activation of a disintegrin and metalloprotease’ (ADAM), 
epidermal growth factor receptor EGFR and the MAPK pathway {Y. Itoh, 2005 #26} 
{A. Li, 2003 #48}. IL-6 signals through gp130 which is linked to activation of both 
the JAK/STAT pathway and the MAPK pathway {T. Taga, 1997 #22}. Both these 
pathways play a role in cell survival and proliferation {P. C. Heinrich, 2003 #65} {G. 
L.Johnson, 2002 #64}. IL-6 could therefore be a candidate for effecting histamine 
induced FHL-124 proliferation through activation of the JAK/STAT and MAPK 
pathways. IL-8 could also be a candidate through activation of PLC {D. Wu, 1993 
#49}. 
 
IL-13 has a wide range of roles throughout the body mainly being involved with 
inflammation and immune system regulation and is known to have functions in 
inhibiting cytokine release. Kaviratne et al showed that IL-13 could induce fibrosis in 
Schistosoma mansoni infected cells in mice through a TGF-β independent mechanism 
{M. Kaviratne, 2004 #28}. However other models have shown IL-13 can stimulate 
and activate TGF-β to induce fibrosis {C. G. Lee, 2001 #51}. Further work has also 
shown that IL-13 can modulate collagen production in human skin and keloid 
fibroblasts {A. Oriente, 2000 #52}. IL-13 could therefore play a role in the fibrotic 
processes of PCO and therefore may warrant further investigation. 
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4.2.3 A potential role for antihistamines in the treatment of PCO 
The aim of this work was to analyse histamine within the normal lens but also to 
research a possible role for histamine in the development of PCO.  It was also already 
known that the eye can generate histamine {J. Z. Nowak , 1987 #82} and that 
following surgery an increase in proteins is found in the aqueous humour providing 
the lens with a possible source of histamine {Wormstone, 2002 #50}. What has been 
found with these experiments is that histamine can induce growth in both FHL-124 
cells and human lens cells. As cellular proliferation is a major process in the 
development of PCO histamine could play a role in its development {I. M. 
Wormstone, 2009 #81}. This could be very important as if histamine can be 
conclusively proven to have a role in the development of PCO then antihistamines 
could be used to manage this development. Application of HRH1 antagonists at the 
time of surgery could be used to reduce the contribution of histamine in PCO 
progression and thus have a benefit to the patient.  
 
 
PCO is thought to be caused through introduction of proteins from the breach of the 
blood aqueous barrier in to the aqueous humour, ocular immune privilege and 
sustained autocrine activity of lens epithelial cells {Wormstone, 2002 #50}. Even 
though the increase in proteins in the aqueous humour returns to pre-operative levels 
within weeks laser corrective surgery is not required for PCO until years later. 
Histamine is unlikely to be involved in the autocrine stage of PCO as the gene array 
showed no ability of the lens to generate endogenous histamine. However if histamine 
is shown to play a major role in the early phase of PCO through elevation in the 
aqueous humour and HRH1 activation then antihistamines that target HRH1 
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signalling could be used to prevent or diminish the induction of these autocrine 
systems. This would require treatment with antihistamines for a short time after 
surgery until the protein levels have returned to normal and the inflammatory 
response to surgery had ceased.  
 
There are advantages to using antihistamines over newly developed cytotoxic agents. 
Antihistamines are already proven therapeutic drugs, widely available, and relatively 
cheap. They would require limited clinical testing as they could be used ‘off the 
shelf’. This is a very important prospect that means the role of histamine in the 
development of PCO warrants further investigation. 
 
4.3 Summary  
 
This project set out to investigate any possible role for histamine in the development 
of PCO. To this end it was shown that histamine can induce proliferation, a major 
stage in PCO development, in FHL-124 cells and in capsular bag models. It was 
found that histamine could induce this proliferation through various pathways. It can 
cause calcium mobilisation through the HRH1 receptor and cause an increase in ERK, 
P-38 and JNK. It was also shown that histamine can cause an increase in cytokines 
IL-6 and IL-8. All these open up areas of further investigation for histamines possible 
role in PCO. Do the MAPK pathways play a role in histamine proliferation? What 
affect does an increase in IL-6 and IL-8 have on the lens?  
 
Outside of this main focus analysis of gene array data showed that the lens has 
histamine receptors, HRH1 being the most abundant. It also showed that the lens can 
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not produce histamine as it lacks HDC but can break down histamine. This also raises 
questions about what processes may release histamine into the lens and what function 
this may play, some of which have been speculated on earlier in the discussion. 
 
Any future work should endeavour to investigate further the mechanisms through 
which histamine can induce proliferation but also focus on the role histamine might 
play in the non-pathological lens.  
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